Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Marksans Pharma LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524404NSE Symbol: MARKSANSP/E(TTM):63.28
ISIN Demat:INE750C01026Div & Yield %:0.3EPS(TTM):2.62
Book Value(Rs):25.6820274Market Cap ( Cr.):7513.45Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 655.20658.29599.55433.42424.16294.66
Excise Duty0.000.000.000.000.000.00
Net Sales655.20658.29599.55433.42424.16294.66
Other Income 60.4842.2531.160.177.937.43
Stock Adjustments 10.19-3.89-0.555.632.713.72
Total Income725.87696.65630.16439.22434.80305.81
EXPENDITURE :      
Raw Materials 404.64373.70337.36251.04239.05173.07
Power & Fuel Cost14.2411.4910.908.688.227.02
Employee Cost 56.0960.4654.6448.5146.3345.86
Other Manufacturing Expenses 4.245.256.984.768.388.24
Selling and Administration Expenses 64.7667.5760.0843.8647.1828.72
Miscellaneous Expenses 29.5222.2215.3110.7014.386.34
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure573.49540.68485.28367.55363.54269.24
Operating Profit152.38155.97144.8771.6671.2636.57
Interest 3.613.805.357.296.567.67
Gross Profit148.77152.17139.5264.3764.7028.90
Depreciation16.7417.6615.1911.648.6912.25
Profit Before Tax132.03134.51124.3352.7356.0116.65
Tax29.3430.0228.1911.1511.393.62
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.170.50-2.243.681.000.60
Reported Net Profit102.87103.9998.3837.9043.6212.43
Extraordinary Items -0.050.000.030.03-0.030.00
Adjusted Net Profit102.92103.9998.3537.8743.6512.43
Adjst. below Net Profit -8.640.05-0.20-0.390.030.12
P & L Balance brought forward155.2161.41-32.69-62.74-104.34-113.43
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 15.8210.234.097.472.053.46
P & L Balance carried down233.61155.2161.41-32.69-62.74-104.34
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0025.0025.0010.005.005.00
Earnings Per Share-Unit Curr2.272.542.400.931.070.30
Earnings Per Share(Adj)-Unit Curr2.272.542.400.931.070.30
Book Value-Unit Curr24.5216.9014.6512.3511.5010.48